Adults as young as 50 may now qualify for an respiratory synctial virus vaccine if they have certain health conditions.

Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.

The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...

Amid the sultry summer months, a few signs of fall become apparent, such as the appearance of school supplies on stores ...

The Centers for Disease Control and Prevention (CDC) yesterday declared its investigation into a multistate Salmonella ...

The increase in tetM prevalence in 2020 coincided with the shift away from azithromycin and toward doxycycline for treatment ...

Two new studies demonstrate the impact of respiratory syncytial virus (RSV) in different populations, with one showing that ...

An ecological study finds increased uptake of recommended childhood vaccines was associated with a 47% decrease in the rate ...